Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome (Q38150286)

29 August 2017

title

Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome (English)

1 reference

29 August 2017

Marc A Colaco

1

1 reference

29 August 2017

Robert J Evans

series ordinal

2

1 reference

29 August 2017

publication date

1 October 2013

1 reference

29 August 2017

published in

Current urology reports

1 reference

29 August 2017

volume

14

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

442-447

1 reference

AUA Guideline for the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2 sensitivity of the contractile apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Rational approaches to the treatment of patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Prospective study of intravesical dimethyl sulphoxide in the treatment of chronic inflammatory bladder disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Heparin as antibacterial agent in rabbit bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Treatment of interstitial cystitis with intravesical heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Intravesical nanocrystalline silver decreases experimental bladder inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11934-013-0369-Y

A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis

21 January 2018

1 reference

12 December 2020

The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial.

1 reference

12 December 2020

Non-anticoagulant uses of heparin

1 reference

12 December 2020

Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observations

1 reference

12 December 2020

Predictors of response to intravesical dimethyl-sulfoxide cocktail in patients with interstitial cystitis

1 reference

12 December 2020

A controlled study of dimethyl sulfoxide in interstitial cystitis

1 reference

12 December 2020

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer

1 reference

12 December 2020

Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome

1 reference

12 December 2020

A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis

1 reference

12 December 2020

A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis

1 reference

12 December 2020

Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models.

1 reference

12 December 2020

Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study

1 reference

12 December 2020

Re: Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. E. L. Davis, S. R. El Khoudary, E. O. Talbott, J. Davis and L. J. Regan. J Urol 2008; 179: 1

1 reference

12 December 2020

Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure

1 reference

12 December 2020

Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin

1 reference

12 December 2020

Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC)

1 reference

12 December 2020

The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term followup

1 reference

12 December 2020

10.1007/S11934-013-0369-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1007408829

0 references

1 reference